Abstract

Nanoparticle-Based Brain Targeted Delivery Systems

Aditya Grover, Anjali Hirani and Vijaykumar Sutariya

Numerous deaths are caused every year by the morbidity of brain disorders, namely gliomas. The staggering number of deaths may be contributed by the anatomic blood-brain barrier, restricting access to a number of therapeutic compounds. This article briefly describes the blood-brain barrier and the current state of nanoparticle therapeutics that aim to cross the blood-brain barrier to improve drug delivery to this highly sensitive region.